Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.

Abstract

Human umbilical cord blood-derived mesenchymal stem cells (HUCB-MSCs) have been studied in several models of immune-mediated disease because of their unique immunomodulatory properties. We hypothesized that HUCB-MSCs could suppress the inflammatory response in postischemic kidneys and attenuate early renal injury. In 8- to 10-wk-old male C57BL/6 mice… (More)
DOI: 10.1152/ajprenal.00555.2013

Topics

9 Figures and Tables

Cite this paper

@article{Jang2014EffectOP, title={Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.}, author={H. Jang and Ji Hyeon Park and Ghee Young Kwon and Jung Eun Lee and Wooseong Huh and Hye Jin Jin and Soo Jin Choi and Wonil Oh and Ha Young Oh and Yoon-Goo Kim}, journal={American journal of physiology. Renal physiology}, year={2014}, volume={307 10}, pages={F1149-61} }